|
VRCA | Verrica Pharmaceuticals Inc. |
|
|
VRCA | Verrica Pharmaceuticals Inc. |
| Pharmaceutical Preparations |
| Book value per $ invested | $ -0.32 |
| Leverage | 118.21% |
| Market Cap | $ 31.3m |
| PE | 0.00 |
| Dividend Yield | 0.00% |
| Profit | $ -76.2m |
| Margin | -1010.67% |
Verrica Pharmaceuticals Inc., a dermatological therapy company, develops and markets treatments for people with skin conditions in the United States. The company is headquartered in West Chester, Pennsylvania.